Share

'Very risky' for UK to delay second Covid vaccine dose: Biologics

Decisions related to health care policies and emergencies should be based on data, says Norman Baylor, president and CEO at Biologics Consulting Group.
03:15
Thu, Jan 7 20213:18 AM EST